Navigation Links
Delaying Parkinson’s Diseas

A new study shows anti-inflammatory drugs do prevent the onset of Parkinson’s disease. The study, led by Harvard researchers, shows people who regularly take nonsteroidal// anti-inflammatory drugs (NSAIDs) had a lower risk of Parkinson’s than those who did not take the drugs.

Parkinson’s disease is characterized by the death of neurons in the brain. The result is a loss in motor function. Some NSAIDs appear to be protective in animal studies and they also are shown to reduce the risk of Alzheimer’s disease in humans. This study looked at the results of two previous studies.

The two studies involved nearly 145,000 men and women. All were free of Parkinson’s disease, stroke, and cancer. About 6 percent of men and nearly 4 percent of women reported regular use of NSAIDs. During the follow-up time period, 415 cases of PD were reported. Participants who reported regular use of NSAIDs at the beginning of the study had about a 45-percent lower risk of developing PD than non-regular users.

In an accompanying editorial, Mya Schiess, M.D., from the University of Texas-Houston Medical School, points out the merits and drawbacks of the study. Dr. Schiess says this study indicates a strong positive benefit of NSAIDs, however it is not yet known what the danger level would be for gastrointestinal bleeding and kidney faiure.

Page: 1

Related medicine news :

1. Delaying The Progression Of Alzheimer’s Disease
2. The Effects Of Delaying A Delivery Questioned
3. Delaying pregnancy may lessen life expectancy of the child
4. UK Facing Shortage of Radiotherapists Delaying Cancer Treatment
5. Delaying Hernia Surgery Is Considered A Safe Option
6. NPIL withdraws Parkinson’s dru
7. Parkinson’s Drug Linked to Gamblin
8. New Drug For Parkinson’s Disease With Less Side Effect
9. Embryonic Cells Might Prevent Parkinson’s Disease From Worsenin
10. Magnetic Stimulation For Parkinson’s Diseas
11. Exercising regularly can reduce the risk of Parkinson’s diseas
Post Your Comments:

(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from reveals that behind the ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s ... the world, and the most handsome men, look naturally attractive. Plastic surgery should ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: